A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
Clinical trial NCT03089229 · COMPLETED
Trial details
- NCT number
- NCT03089229
- Sponsor
- Haus Bioceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-26
- Primary completion
- 2017-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.